Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 20, 2026 07:00 ET | Source: NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals (Nasdaq:NRXP) Welcomes Presidential Initiative to Accelerate Approval of Psychedelic Medications to Treat Depression, PTSD, and Suicidality

President Trump signed an Executive Order: ACCELERATING MEDICAL TREATMENTS FOR SERIOUS MENTAL ILLNESS on April 18, 2026.The order directs acceleration of research and lowered barriers to approvals of...
April 20, 2026 07:00 ET | Source: Seres Therapeutics, Inc.

Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026

Pharmacologic data highlight durable GI microbiome modulation, with improvement in epithelial barrier integrity, following SER-155 administration Additional presentations underscore the role of live...
April 20, 2026 06:34 ET | Source: Silo Pharma, Inc.

Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics

SPC-15 Intranasal PTSD Program Aligns with Federal Push to Fast-Track Novel Mental Health Therapies SARASOTA, Fla., April 20, 2026 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (NASDAQ: SILO), a...
April 20, 2026 06:00 ET | Source: Greenwich LifeSciences, Inc.

Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR Meeting 2026

STAFFORD, Texas, April 20, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial,...
April 20, 2026 06:00 ET | Source: USA Rare Earth, Inc.

USA Rare Earth Announces Definitive Agreement to Acquire Serra Verde Group for ~$2.8 Billion, Creating the Global Rare Earth Leader

Secures One of the Industry’s Most Strategic Operations as the Only Scaled Producer of all Four Magnetic Rare Earth Elements Outside Asia, along with a 15-Year 100% Offtake Agreement with a Special...
April 20, 2026 05:28 ET | Source: Precedence Research

Halal Ingredients Market Size to Exceed USD 196.84 Billion by 2035, Driven by Rising Consumer Demand and Regulatory Developments

Ottawa, April 20, 2026 (GLOBE NEWSWIRE) -- The global halal ingredients market size stood at USD 92.45 billion in 2025 and is predicted to grow from USD 99.71 billion in 2026 to approximately USD...
April 20, 2026 03:17 ET | Source: Mordor Intelligence

Urology Devices Market to Reach $58.63 Billion by 2031 with Robotic Urologic Surgery Systems Projected to Expand at a 10.31% CAGR, Reports Mordor Intelligence

Hyderabad, India, April 20, 2026 (GLOBE NEWSWIRE) -- According to Mordor Intelligence, the urology devices market size is projected to increase from USD 39.65 billion in 2025 to USD 42.32 billion in...
April 19, 2026 08:00 ET | Source: Fedora Pharmaceuticals, Inc.

Fedora Pharmaceuticals Presentations at 2026 ESCMID Highlight Safety and Potent Bactericidal Activity of FPI-2119

EDMONTON, Alberta , April 19, 2026 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc., a leader in the development of drugs to treat antibiotic-resistant infections, is presenting a full suite of...
April 18, 2026 10:59 ET | Source: Beond, Inc.

Beond Issues Statement on President Trump’s Executive Order on Psychedelics

$50 Million Federal Commitment to Ibogaine Research; Accelerates Pathway for Access to Life-Saving Treatments A Defining Moment for Brain Health Innovation in the United States AUSTIN, Texas, April ...
April 17, 2026 17:18 ET | Source: Rocket Doctor AI Inc.

Rocket Doctor Amends 45 Degree Agreement

Vancouver, BC, April 17, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that, subject to regulatory approval, it has entered...